A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration

Osteoporosis International

Volumn 21, Issue 10, 2010, Pages 1723-1729

  Carvas, J S B ^a   Pereira, R M R ^a   Caparbo, V F ^a   Fuller, P ^a   Silveira, C A ^a   Lima, L A P ^a   Bonfa, E ^a   Mello, S B V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone; Glucocorticoid; Osseointegration; Titanium implants; Zoledronic acid

Indexed keywords

METHYLPREDNISOLONE; TITANIUM; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE REGENERATION; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG EFFECT; DRUG EFFICACY; IMPLANT; MALE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; GLUCOCORTICOIDS; IMIDAZOLES; LUMBAR VERTEBRAE; MALE; METHYLPREDNISOLONE; ORTHOPEDIC FIXATION DEVICES; OSSEOINTEGRATION; OSTEOPOROSIS; PROSTHESES AND IMPLANTS; RABBITS; TIBIA; TITANIUM;

EID: 77956399492     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-1125-5     Document Type: Article

References (52)

1. Branemark PI, Grondahl K, Branemark BK (2005) Why osseointegration would work and how it did in the first patients treated. Basic facts and philosophical thoughts. The osseointegration book: from calvarium to calcaneus, chapter 3, 1st edn. Quintessenz, Berlin
2. RZ LeGeros RG Craig 1993 Strategies to affect bone remodeling: osteointegration J Bone Miner Res 8 583 596 10.1002/jbmr.5650081328
3. AS el Askary RM Meffert T Griffin 1999 Why do dental implants fail? Part I Implant Dentistry 8 2 173 185 10635160
4. GG Lugero VF Caparbo ML Guzzo B Konig V Jorgetti 2000 Histomorphometric evaluation of implants in osteoporotic rabbits Implant Dent 9 303 309 1:STN:280:DC%2BD3MzisFSgtg%3D%3D 10.1097/00008505-200009040-00005 11307552
5. N Von Wowern 2001 General and oral aspects of osteoporosis: a review Clin Oral Investig 5 71 82 10.1007/s007840100105
6. CE Sakakura G Giro D Gonçalves RM Pereira SR Orrico E Marcantonio Jr 2006 Radiographic assessment of bone density around integrated titanium implants after ovariectomy in rats Clin Oral Impl Res 17 134 138 10.1111/j.1600-0501.2005.01224.x
7. PM Duarte GR Nogueira Filho EA Sallum S de Toledo AW Sallum FH Nociti Júnior 2001 The effect of an immunosuppressive therapy and its withdrawal on bone healing around titanium implants. A histomorfometric study in rabbits J Periodontol 10 1391 1397 10.1902/jop.2001.72.10.1391
8. T Beikler TF Fleming 2003 Implants in the medically compromised patient Crit Rev Oral Biol Med 4 305 316 10.1177/154411130301400407
9. EF Morand 2007 Effects of glucocorticoids on inflammation and arthritis Curr Opin Rheumatol 19 3 302 307 1:CAS:528:DC%2BD2sXjvFClt7k%3D 10.1097/BOR.0b013e32805e87d0 17414960
10. AD Woolf 2007 An update on glucocorticoid-induced osteoporosis Curr Opin Rheumatol 19 370 375 1:CAS:528:DC%2BD2sXmtV2qtLc%3D 17551369
11. JC Keller M Stewart M Roehm GB Schneider 2004 Osteoporosis-like bone conditions affect osseointegration of implants Int J Oral Maxillofac Implants 19 5 687 694 15508984
12. M Yamazaki T Shirota Y Tokugawa M Motohashi K Ohno K Michi A Yamaguchi 1999 Bone reactions to titanium screw implants in ovariectomized animals Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87 4 411 418 1:STN:280: DyaK1M3ktVWmsA%3D%3D 10.1016/S1079-2104(99)70239-8 10225622
13. M Motohashi T Shirota Y Tokugawa K Ohno K Michi A Yamaguchi 1999 Bone reactions around hydroxyapatite-coated implants in ovariectomized rats Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87 2 145 152 1:STN:280: DyaK1M7lvFOgsA%3D%3D 10.1016/S1079-2104(99)70264-7 10052367
14. RR Recker PD Delmas J Halse IR Reid S Boonen PA García-Hernandez J Supronik EM Lewiecki L Ochoa P Miller H Hu P Mesenbrink F Hartl J Gasser EF Eriksen 2008 Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure J Bone Miner Res 23 6 16 1:CAS:528: DC%2BD1cXhtVCmt7c%3D 10.1359/jbmr.070906 17892374
15. JE Brown SP Ellis JE Lester S Gutcher T Khanna OP Purohit E McCloskey RE Coleman 2007 Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid Clin Cancer Res 13 5406 5410 1:CAS:528:DC%2BD2sXhtVCitLzI 10.1158/1078-0432.CCR-07-0247 17875770
16. Y Gao S Zou X Liu C Bao J Hu 2009 The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats Biomaterials 30 9 1790 1796 1:CAS:528:DC%2BD1MXht1ejsLY%3D 10.1016/j.biomaterials.2008.12.025 19135249
17. JD Bobyn SA Hacking JJ Krygier EJ Harvey DG Little M Tanzer 2005 Zoledronic acid causes enhancement of bone growth into porous implants J Bone Joint Surg Br 87 416 420 1:STN:280:DC%2BD2M7ktFOqsw%3D%3D 10.1302/0301-620X. 87B3.14665 15773657
18. LM Wise SD Waldman M Kasra R Cheung A Binnington RA Kandel LM White MD Grynpas 2005 Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog Calcif Tissue Int 77 6 367 375 1:CAS:528:DC%2BD2MXhtlemurnL 10.1007/s00223-005-0062-3 16362454
19. I Masoud F Shapiro R Kent A Moses 1986 A longitudinal study of the growth of the New Zealand white rabbit: cumulative and biweekly incremental growth rates for body length, body weight, femoral length, and tibial length J Orthop Res 4 2 221 231 1:STN:280:DyaL283is1yjsw%3D%3D 10.1002/jor.1100040211 3712130
20. CA Luppen CA Blake KM Ammirati ML Stevens HJ Seeherman JM Wozney ML Bouxsein 2002 Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits J Bone Miner Res 17 2 301 310 1:CAS:528:DC%2BD38XhtVymurk%3D 10.1359/jbmr.2002.17.2.301 11811561
21. RV Waters SC Gamradt P Asnis BH Vickery Z Avnur E Hill M Bostrom 2000 Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model Acta Orthop Scand 71 3 316 321 1:STN:280:DC%2BD3czpvFGhtw%3D%3D 10.1080/000164700317411951 10919307
22. DG Little NC Smith PR Williams JN Briody LE Bilston EJ Smith EM Gardiner CT Cowell 2003 Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis J Bone Miner Res 18 1300 1307 1:CAS:528:DC%2BD3sXlsFGktLs%3D 10.1359/jbmr.2003.18.7.1300 12854841
23. AL Coelho M Suzuki S Dibart N DA Silva PG Coelho 2007 Cross-sectional analysis of the implant-abutment interface J Oral Rehabil 34 7 508 516 1:STN:280:DC%2BD2szks1Cnsw%3D%3D 10.1111/j.1365-2842.2007.01714.x 17559619
24. Schenk RK, Olah AJ, Herrmann W (1984) Preparation of calcified tissues for light microscopy. In: Dickson GR (ed) Methods of calcified tissue preparation. Elsevier Science, Amsterdam, pp 1-56
25. 2/HCl treated titanium implants: an experimental study in the rabbit Int J Oral Maxillofac Surg 38 6 677 681 1:STN:280:DC%2BD1Mvgt1ajtg%3D%3D 10.1016/j.ijom.2009.03.716 19406618
26. FH Nociti Jr CM Stefani EA Sallum PM Duarte AW Sallum 2002 Nicotine and bone density around titanium implants: a histometric study in rabbits Implant Dent 11 2 176 182 10.1097/00008505-200204000-00020 12083062
27. JA Gasser P Ingold A Venturiere V Shen JR Green 2008 Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat J Bone Miner Res 23 544 551 1:CAS:528:DC%2BD1cXltFyhsbg%3D 10.1359/jbmr.071207 18072878
28. JWJ Bijlsma A Van Everdingen M Huisman RNJTL De Nijs JWG Jacobs 2002 Glucocorticoids in rheumatoid arthritis Ann NY Acad Sci 966 82 90 1:CAS:528:DC%2BD38XlvVWmsbc%3D 10.1111/j.1749-6632.2002.tb04205.x 12114262
29. O Di Munno A Delle Sedie 2008 Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis J Endocrinol Invest 31 7 43 47 18791351
30. S Castañeda E Calvo R Largo R González-González C de la Piedra M Díaz-Curiel G Herrero-Beaumont 2008 Characterization of a new experimental model of osteoporosis in rabbits J Bone Miner Metab 26 1 53 59 10.1007/s00774-007-0797-1 18095064
31. LJ Walsh CA Wong M Pringle AE Tattersfield 1996 Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study BMJ 313 7053 344 346 1:STN:280:DyaK28zktlOmsg%3D%3D 8760745
32. V Naganathan G Jones P Nash G Nicholson J Eisman PN Sambrook 2000 Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use Arch Intern Med 160 19 2917 2922 1:STN:280:DC%2BD3crgt1Wlug%3D%3D 10.1001/archinte.160.19.2917 11041898
33. BA Michel DA Bloch JF Fries 1991 Predictors of fractures in early rheumatoid arthritis J Rheumatol 18 6 804 808 1:STN:280:DyaK3MznsVCjsw%3D%3D 1895260
34. AD Adinoff JR Hollister 1983 Steroid-induced fractures and bone loss in patients with asthma N Engl J Med 309 5 265 268 1:STN:280:DyaL3s3ksVyrtA%3D%3D 10.1056/NEJM198308043090502 6866051
35. TP Van Staa RF Laan IP Barton S Cohen DM Reid C Cooper 2003 Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy Arthritis Rheum 48 3224 3229 10.1002/art.11283 14613287
36. JA Kanis H Johansson A Oden O Johnell C de Laet LJ Melton III A Tenenhouse J Reeve AJ Silman HA Pols JA Eisman EV McCloskey D Mellstrom 2004 A meta-analysis of prior corticosteroid use and fracture risk J Bone Miner Res 19 6 893 899 10.1359/JBMR.040134 15125788
37. NF Peel DJ Moore NA Barrington DE Bax R Eastell 1995 Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis Ann Rheum Dis 54 10 801 806 1:STN:280:DyaK28%2FpslOiuw%3D%3D 10.1136/ard.54.10.801 7492217
38. Y Gao E Luo J Hu J Xue S Zhu J Li 2009 Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats Bone 44 2 225 232 1:CAS:528:DC%2BD1MXhtFSmtLk%3D 10.1016/j.bone.2008.10.054 19056525
39. T Ogoshi H Hagino S Fukata S Tanishima T Okano R Teshima 2008 Influence ofglucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry Mod Rheumatol 18 6 552 561 1:CAS:528: DC%2BD1cXhsVKhtrzM 10.1007/s10165-008-0096-2 18648735
40. H Mori M Manabe Y Kurachi M Naguno 1997 Osseointegration of dental implants in rabbit bone with low mineral density J Oral Maxillofac Surg 55 351 361 1:STN:280:DyaK2s3lsl2ktg%3D%3D 10.1016/S0278-2391(97)90124-5 9120698
41. AF Mavrogenis R Dimitriou J Parvizi GCJ Babis 2009 Biology of implant osseointegration J Musculoskelet Neuronal Interact 9 2 61 71 1:STN:280:DC%2BD1MvgvFOqsA%3D%3D 19516081
42. K Hirakawa JJ Jacobs R Urban T Saito 2004 Mechanisms of failure of total hip replacements: lessons learned from retrieval studies Clin Orthop Relat Res 420 10 17 10.1097/00003086-200403000-00003 15057073
43. DM Lack PD Delmas R Eastell IR Reid S Boonen JA Cauley F Cosman P Lakatos PC Leung Z Man C Mautalen P Mesenbrink H Hu J Caminis K Tong T Rosario-Jansen J Krasnow TF Hue D Sellmeyer EF Eriksen SR Cummings 2007 HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis N Engl J Med 356 18 1809 1822 10.1056/NEJMoa067312
44. DM Reid JP Devogelaer K Saag C Roux CS Lau JY Reginster P Papanastasiou A Ferreira F Hartl T Fashola P Mesenbrink PN Sambrook HORIZON investigators 2009 Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial Lancet 373 9671 1253 1263 1:CAS:528:DC%2BD1MXktlyqtb4%3D 10.1016/S0140-6736(09)60250-6 19362675
45. SH Greiner B Wildemann DA Back M Alidoust P Schwabe NP Haas G Schmidmaier 2008 Local application of zoledronic acid incorporated in a poly(d, l-lactide)-coated implant accelerates fracture healing in rats Acta Orthop 79 5 717 725 10.1080/17453670810016768 18839381
46. S Greiner A Kadow-Romacker B Wildemann P Schwabe G Schmidmaier 2007 Bisphosphonates incorporated in a poly(d, l-lactide) implant coating inhibit osteoclast like cells in vitro J Biomed Mater Res A 83 4 1184 1191 17595027
47. S Greiner A Kadow-Romacker M Lübberstedt G Schmidmaier B Wildemann 2007 The effect of zoledronic acid incorporated in a poly(D, L-lactide) implant coating on osteoblasts in vitro J Biomed Mater Res 80 4 769 775 1:STN:280:DC%2BD2s%2Fpt1ehsg%3D%3D 10.1002/jbm.a.30950
48. SJ Suratwala SK Cho JJ van Raalte SH Park SW Seo SS Chang TR Gardner FY Lee 2008 Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite J Bone Joint Surg Am 90 10 2189 2196 10.2106/JBJS.G.00409 18829917
49. YN You KR Short M Jourdan KA Klaus S Walrand KS Nair 2009 The effect of high glucocorticoid administration and food restriction on rodentskeletal muscle mitochondrial function and protein metabolism PLoS ONE 4 4 e5283 10.1371/journal.pone.0005283 19381333
50. M Kugelberg K Shafiei C Ohlsson L Sävendahl C Zetterström 2005 Glucocorticoid eye drops inhibit growth in the newborn rabbit Acta Paediatr 94 8 1096 1101 10.1080/08035250510028731 16188855
51. LP de Lorimier TM Fan 2005 Bone metabolic effects of single-dose zoledronate in healthy dogs J Vet Intern Med 19 6 924 927 10.1111/j.1939-1676. 2005.tb02790.x 16355693
52. M Arden-Cordone ES Siris KW Lyles A Knieriem RA Newton V Schaffer K Zelenakas 1997 Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone Calcif Tissue Int 60 5 415 418 1:CAS:528:DyaK2sXivVejtrY%3D 10.1007/s002239900255 9115157